BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36361585)

  • 1. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17.
    Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
    Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
    J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.
    Tang B; Li X; Maretzky T; Perez-Aguilar JM; McIlwain D; Xie Y; Zheng Y; Mak TW; Weinstein H; Blobel CP
    FASEB J; 2020 Apr; 34(4):4956-4969. PubMed ID: 32103528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iRhom2 controls the substrate selectivity of stimulated ADAM17-dependent ectodomain shedding.
    Maretzky T; McIlwain DR; Issuree PD; Li X; Malapeira J; Amin S; Lang PA; Mak TW; Blobel CP
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11433-8. PubMed ID: 23801765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
    Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
    J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of iRhoms 1 and 2 in Endochondral Ossification.
    Fang R; Haxaire C; Otero M; Lessard S; Weskamp G; McIlwain DR; Mak TW; Lichtenthaler SF; Blobel CP
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling.
    Li X; Maretzky T; Weskamp G; Monette S; Qing X; Issuree PD; Crawford HC; McIlwain DR; Mak TW; Salmon JE; Blobel CP
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6080-5. PubMed ID: 25918388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
    Al-Salihi MA; Lang PA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pseudoprotease iRhom1 controls ectodomain shedding of membrane proteins in the nervous system.
    Tüshaus J; Müller SA; Shrouder J; Arends M; Simons M; Plesnila N; Blobel CP; Lichtenthaler SF
    FASEB J; 2021 Nov; 35(11):e21962. PubMed ID: 34613632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Induction of the ADAM17 Regulators iRhom1 and 2 in Endothelial Cells.
    Babendreyer A; Rojas-González DM; Giese AA; Fellendorf S; Düsterhöft S; Mela P; Ludwig A
    Front Cardiovasc Med; 2020; 7():610344. PubMed ID: 33335915
    [No Abstract]   [Full Text] [Related]  

  • 11. The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release.
    Düsterhöft S; Kahveci-Türköz S; Wozniak J; Seifert A; Kasparek P; Ohm H; Liu S; Kopkanova J; Lokau J; Garbers C; Preisinger C; Sedlacek R; Freeman M; Ludwig A
    Cell Mol Life Sci; 2021 Jun; 78(11):5015-5040. PubMed ID: 33950315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletions in the cytoplasmic domain of iRhom1 and iRhom2 promote shedding of the TNF receptor by the protease ADAM17.
    Maney SK; McIlwain DR; Polz R; Pandyra AA; Sundaram B; Wolff D; Ohishi K; Maretzky T; Brooke MA; Evers A; Vasudevan AA; Aghaeepour N; Scheller J; Münk C; Häussinger D; Mak TW; Nolan GP; Kelsell DP; Blobel CP; Lang KS; Lang PA
    Sci Signal; 2015 Nov; 8(401):ra109. PubMed ID: 26535007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory activation of surface molecule shedding by upregulation of the pseudoprotease iRhom2 in colon epithelial cells.
    Giese AA; Babendreyer A; Krappen P; Gross A; Strnad P; Düsterhöft S; Ludwig A
    Sci Rep; 2021 Dec; 11(1):24230. PubMed ID: 34930929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Status update on iRhom and ADAM17: It's still complicated.
    Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.
    Rabinowitsch AI; Maretzky T; Weskamp G; Haxaire C; Tueshaus J; Lichtenthaler SF; Monette S; Blobel CP
    J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37282854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACE.
    Cavadas M; Oikonomidi I; Gaspar CJ; Burbridge E; Badenes M; Félix I; Bolado A; Hu T; Bileck A; Gerner C; Domingos PM; von Kriegsheim A; Adrain C
    Cell Rep; 2017 Oct; 21(3):745-757. PubMed ID: 29045841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iRhom2 regulates ectodomain shedding and surface expression of the major histocompatibility complex (MHC) class I.
    Calligaris M; Spanò DP; Bonelli S; Müller SA; Carcione C; D'apolito D; Amico G; Miele M; Di Bella M; Zito G; Nuti E; Rossello A; Blobel CP; Lichtenthaler SF; Scilabra SD
    Cell Mol Life Sci; 2024 Apr; 81(1):163. PubMed ID: 38570362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
    Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
    J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A structural model of the iRhom-ADAM17 sheddase complex reveals functional insights into its trafficking and activity.
    Kahveci-Türköz S; Bläsius K; Wozniak J; Rinkens C; Seifert A; Kasparek P; Ohm H; Oltzen S; Nieszporek M; Schwarz N; Babendreyer A; Preisinger C; Sedlacek R; Ludwig A; Düsterhöft S
    Cell Mol Life Sci; 2023 Apr; 80(5):135. PubMed ID: 37119365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.
    Li X; Maretzky T; Perez-Aguilar JM; Monette S; Weskamp G; Le Gall S; Beutler B; Weinstein H; Blobel CP
    J Cell Sci; 2017 Mar; 130(5):868-878. PubMed ID: 28104813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.